131 – 140 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
(
- Contribution to journal › Article
-
Mark
Contact-system activation in children with vasculitis.
(
- Contribution to journal › Article
-
Mark
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans
(
- Contribution to journal › Article
- 2001
-
Mark
Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia
(
- Contribution to journal › Article
-
Mark
Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle
(
- Contribution to journal › Article
- 2000
-
Mark
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
(
- Contribution to journal › Article
-
Mark
Binding of immune complexes to erythrocyte CR1 (CD35): difference in requirement of classical pathway components and indication of alternative pathway-mediated binding in C2-deficiency
(
- Contribution to journal › Article
-
Mark
Novel roles of complement in systemic lupus erythematosus - Hypothesis for a pathogenetic vicious circle
(
- Contribution to journal › Article
- 1999
-
Mark
Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups
(
- Contribution to journal › Article